)
)
PanSolid: Driving Diagnostic Innovation and Genomic Insights for Solid Tumours at NW GLH
From our work at the North West Genomic Laboratory Hub (NW‑GLH), we will share key achievements from deploying our PanSolid assay, including:
- Expanded variant detection across clinically relevant genes and pathways
- Diagnostic applications that improve confidence in patient results and support precision medicine
- Streamlined workflows that reduce turnaround time without compromising accuracy
- Scalable implementation across diagnostic, research and translational settings
- Case studies demonstrating how PanSolid has accelerated discovery and improved diagnostic reliability
- Future developments, including enhanced automation, integration with emerging bioinformatics pipelines, and expansion into new clinical domains
